Skip to content
MedsAcross

Brand family

Hizentra

European UnionUnited States
Presentations
4
Markets
2

Hizentra is a brand of Human immunoglobulin g and Human normal immunoglobulin marketed by CSL Behring, with 4 presentations listed and registered in European Union, United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Human immunoglobulin g, Human normal immunoglobulin
Brand owner
CSL Behring
Registered in
European Union, United States
Strengths and forms
1 g/5 mL injection, 10 g/50 mL injection, 2 g/10 mL injection, 4 g/20 mL injection

All presentations

MedicineManufacturerRegisterAvailability
Hizentra 1 g/5 mL injectionSubcutaneousCSL BehringUS FDAAvailable on request
Hizentra 10 g/50 mL injectionSubcutaneousCSL BehringUS FDAAvailable on request
Hizentra 2 g/10 mL injectionSubcutaneousCSL BehringUS FDAAvailable on request
Hizentra 4 g/20 mL injectionSubcutaneousCSL BehringUS FDAAvailable on request

Equivalent brands

Other brands of Human immunoglobulin g and Human normal immunoglobulin.

Brand names and trademarks belong to their owners and are used only to identify products.

Request Hizentra

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.